This website is initiated and funded by Recordati Pharmaceuticals Ltd. This website is intended for members of the public in the UK.
Our Medicines
We provide prescription and self-medication treatments across a range of therapeutic areas.
Our Medicines
The information supplied on this page is intended for members of the public.
Please note that this information is specific to the UK and is not intended to replace the advice of healthcare professionals.
Cardiovascular
Product Name & Generic
Central nervous system
Gastroenterology
Product Name & Generic
|
Product Name
|
Active Ingredient
|
UK Summary of Product Characteristics
|
UK Patient Information Leaflet
|
Ireland Summary of Product Characteristics & Package Leaflet
|
|---|---|---|---|---|
|
Carbaglu
|
carglumic acid
|
|||
|
Cosmegen Lyovac
|
dactinomycin
|
Not available
|
||
|
Cystadane
|
betaine anhydrous
|
|||
|
Cystadrops
|
mercaptamine hydrochloride
|
|||
|
Cystagon
|
mercaptamine bitartrate
|
|||
|
Enjaymo▼
|
sutimlimab
|
Not available
|
Not available
|
|
|
Fotivda
|
tivozanib hydrochloride monohydrate
|
|||
|
*Isturisa▼
|
osilodrostat phosphate
|
|||
|
Ledaga
|
chlormethine hydrochloride
|
|||
|
Normosang
|
human hemin
|
Not available
|
||
|
Pedea
|
ibuprofen
|
|||
|
Qarziba▼
|
dinutuximab beta
|
|||
|
Signifor
|
pasireotide diaspartate
|
|||
|
Signifor
|
pasireotide pamoate
|
|||
|
Sylvant▼
|
siltuximab
|
|||
|
Vedrop▼
|
tocofersolan
|
|||
|
Wilzin
|
zinc acetate dihydrate
|
*Isturisa is not subject to additional monitoring in Ireland.
Reporting Adverse Events
For Patients and Carers
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk for how to report side effects.
If you experience any adverse effects whilst taking our medicines, please speak to your doctor, pharmacist, or nurse. Adverse events should always be reported. This includes any possible adverse effects not listed in the package leaflet. You can report adverse effects directly to the MHRA via the Yellow Card Scheme at: https://yellowcard.mhra.gov.uk. By reporting adverse effects, you can help provide more information on the safety of your medicine. Adverse events should also be reported to Recordati Pharmaceuticals Limited at .
For Healthcare Professionals
Adverse events should always be reported:
- Report directly to the MHRA via the Yellow Card Scheme: yellowcard.mhra.gov.uk
- Report to Recordati:
By reporting adverse effects, you help provide more information on the safety of medicines.
